Product image of Junaya (Dienogest, Ethinylestradiol) supplied by GNH India

Junaya

Active Ingredient:
Dienogest, Ethinylestradiol
Origin:
EU

Junaya (Dienogest, Ethinylestradiol)

Dienogest / Ethinylestradiol, the active ingredients in Junaya, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and the endometrium.
GNH India supplies Junaya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Nextgen Pharma S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Junaya, a combined oral contraceptive, is used to prevent pregnancy by suppressing ovulation and modifying the uterine environment.
  • Prevention of pregnancy: provides reliable contraception for women of childbearing potential.
  • Regulation of menstrual cycles: helps achieve more predictable bleeding patterns.
  • Acne management: reduces androgen‑related acne in women using hormonal contraception.
  • Treatment of dysmenorrhea: alleviates painful menstrual cramps associated with ovulatory cycles.

How It Works

  • Junaya combines dienogest, a progestogenic agent, with ethinylestradiol, an estrogenic compound. The estrogen component suppresses follicle‑stimulating hormone release, while the progestogen inhibits luteinizing hormone surge, preventing ovulation. Together they thicken cervical mucus and induce endometrial changes that reduce sperm penetration and implantation potential, achieving contraceptive efficacy.

Side Effects

Common Side Effects

  • Nausea or mild gastrointestinal upset.
  • Breast tenderness or enlargement.
  • Headache or migraine onset.
  • Breakthrough or spotting bleeding.
  • Weight fluctuation or fluid retention.
  • Mood changes or irritability.

Serious or Rare Side Effects

  • Venous thromboembolism (deep vein thrombosis, pulmonary embolism).
  • Arterial thrombosis (stroke, myocardial infarction).
  • Severe hypertension.
  • Hepatic adenoma or tumor.
  • Anaphylactic or severe allergic reaction.
  • Visual disturbances indicating retinal vascular events.

Precautions & Warnings

Junaya requires careful assessment before initiation and during therapy.

  • Contraindicated in pregnancy: category X, must not be used.
  • Avoid in women with a history of thromboembolic disease or clotting disorders.
  • Do not use in smokers over 35 years of age due to increased cardiovascular risk.
  • Monitor blood pressure regularly; discontinue if hypertension develops.
  • Assess liver function; avoid in severe hepatic impairment.
  • Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Junaya may interact with several drug classes, affecting efficacy or safety.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin) may markedly reduce contraceptive effectiveness.
  • Concurrent use with anticoagulants can increase bleeding risk.
  • Certain antiretrovirals (e.g., protease inhibitors) may alter hormone levels.

Moderate Interactions (Monitor Closely)

  • SSRIs or other antidepressants may heighten mood‑related side effects.
  • Antihypertensive agents may require dose adjustment due to estrogen‑induced fluid retention.
  • Herbal supplements such as St. John's wort can diminish contraceptive efficacy.
  • Non‑steroidal anti‑inflammatory drugs may increase risk of gastrointestinal irritation.

Frequently Asked Questions

Junaya is a prescription combined oral contraceptive containing dienogest and ethinylestradiol. It is used to prevent unintended pregnancy in women of reproductive age by suppressing ovulation and creating cervical and endometrial conditions that are unfavorable for fertilization and implantation.

Dienogest is a synthetic progestogen that binds to progesterone receptors, inhibiting the luteinizing hormone surge needed for ovulation. It also thickens cervical mucus and alters the endometrium, reducing the likelihood of sperm penetration and implantation when combined with the estrogen component.

The dosing regimen for Junaya is determined by the prescribing healthcare professional. Typically, it is taken as a daily oral tablet following the specific cycle schedule indicated on the prescription label.

Junaya is classified as pregnancy category X, meaning it must not be used during pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as hormonal exposure may affect milk production and infant safety.

To order Junaya, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Junaya combines dienogest, a third‑generation progestogen, with ethinylestradiol, offering a balance of contraceptive efficacy and a potentially lower risk of androgenic side effects compared with older progestins. Its safety profile and tolerability are comparable to other modern combined oral contraceptives, but individual response may vary.

Junaya tablets should be stored at ambient temperature below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure they are out of reach of children.

Junaya is taken orally, usually once daily at the same time each day, following the prescribed cycle (e.g., 21 active tablets followed by a placebo week). Swallow the tablet whole with water; do not split or chew.

The most serious risks include venous or arterial thromboembolism, severe hypertension, hepatic adenoma, and rare allergic reactions. Women with a history of clotting disorders, smoking over age 35, or uncontrolled hypertension should avoid use.

Junaya should not be used by women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, are smokers over 35 years old, have uncontrolled hypertension, or have severe liver disease. Contraindications are outlined in the prescribing information.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dienogest, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT